Acquisitions, Dispositions, and Funded Research and Development Arrangements (Tables)

3 Months Ended

Jul. 31, 2026

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

Schedule of Business Combination, Recognized Asset Acquired and Liability Assumed

The following tables summarize the preliminary fair value of consideration transferred and the preliminary fair values of the assets acquired and liabilities assumed:


(in millions)	Scientia		SPR
Cash consideration paid at closing	$	527	$	654
Fair value of contingent consideration	123		—
Total consideration transferred	651		654
Settlement of debt and accrued interest	30		—
Total purchase price	$	681	$	654


(in millions)	Scientia		SPR
Current assets (excluding inventory)	$	21	$	27
Inventory	33		31
Total current assets	54		58
Property, plant, and equipment, net	23		2
Goodwill	511		422
Other intangible assets	278		241
Other noncurrent assets	8		8

Total assets acquired	874		731

Other current liabilities	7		13
Accrued income taxes	145		—
Total current liabilities	151		13
Deferred tax liabilities	—		59

Other noncurrent liabilities	42		4
Total liabilities assumed	193		77

Net assets acquired	$	681	$	654

The following tables summarize the preliminary fair value of consideration transferred and the preliminary fair values of the assets acquired and liabilities assumed:


(in millions)
Cash consideration paid at closing	$	410
Fair value of contingent consideration	115
Total consideration transferred	525
Fair value of previously held equity interest in CathWorks	93
Settlement of debt and accrued interest due from CathWorks	88
Settlement of pre-existing relationships	12
Total purchase price	$	718


(in millions)
Current assets	$	17
Property, plant, and equipment, net	11
Goodwill	555
Other intangible assets	200
Other assets	1
Total assets acquired	784

Current liabilities	7
Accrued income taxes	38
Total current liabilities	45
Deferred tax liabilities	21
Other noncurrent liabilities	1
Total liabilities assumed	66

Net assets acquired	$	718

Schedule of Reconciliation of Beginning and Ending Balances of Contingent Consideration Associated with Acquisitions

The following table provides a reconciliation of the beginning and ending balances of contingent consideration liabilities:


	Three months ended
(in millions)	July 31, 2026
Beginning balance	$	163
Purchase price contingent consideration	123
Purchase price allocation adjustments	3
Payments	(14)

Ending balance	$	275

Schedule of Significant Unobservable Inputs

The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:


(in millions)	Fair Value at July 31, 2026		Unobservable Input	Range	Weighted Average (1)
Revenue and other performance-based payments	$	220	Discount rate	7.8% - 28.2%	11.1%
			Projected fiscal year of payment	2027 - 2031	2029
Product development and other milestone-based payments	$	55	Discount rate	5.5%	5.5%
			Projected fiscal year of payment	2027 - 2028	2027

(1)Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.